Biosynthesis and degradation of CFTR

Area of Science:

• Molecular Biology
• Cell Biology
• Genetics

Background:

• Cystic fibrosis is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
• Many CFTR mutations lead to misfolding and impaired biosynthesis of the CFTR protein.
• Misfolded CFTR is typically degraded before reaching the cell membrane.

Purpose of the Study:

• To investigate the impact of CFTR mutations on protein folding and degradation.
• To explore the mechanisms of mutant CFTR processing in the endoplasmic reticulum.
• To identify potential therapeutic targets for cystic fibrosis.

Main Methods:

• Analysis of nascent CFTR molecules with disease-causing mutations.
• Investigation of CFTR processing through the secretory pathway.
• Examination of CFTR degradation by cytoplasmic proteasomes.
• Assessment of multiubiquitination in mutant CFTR degradation.
• Evaluation of temperature and chemical chaperones on CFTR processing.

Main Results:

• Mutations, including DeltaF508, significantly reduce CFTR folding efficiency.
• Mutant CFTR exhibits reduced dissociation from molecular chaperones.
• Impaired maturation prevents mutant CFTR from reaching the plasma membrane.
• Rapid degradation of misfolded CFTR occurs via proteasomes through multiubiquitination.

Conclusions:

• CFTR misfolding and subsequent degradation are key events in cystic fibrosis pathogenesis.
• Intracellular processing of mutant CFTR is sensitive to temperature and chemical chaperones.
• Enhancing CFTR folding in vivo presents a promising therapeutic avenue for cystic fibrosis.